OIMU
BMY icon

Orbis Investment Management (US)’s Bristol-Myers Squibb BMY Stock Holding History

Orbis Investment Management (US)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$4.67M Buy
89,763
+39,011
+77% +$2.1M 4.68% 10
2018
Q3 		$3.15M Buy
+50,752
New +$3.01M 2.28% 17
2018
Q2 		– Sell
-108,939
Closed -$6.89M – 23
2018
Q1 		$6.89M Sell
108,939
-5,888
-5% -$379K 4.8% 6
2017
Q4 		$7.04M Sell
114,827
-2,936
-2% -$184K 4.77% 8
2017
Q3 		$7.51M Buy
+117,763
New +$6.88M 4.67% 8

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Orbis Investment Management (US)'s BMY Position: Q4 2018 in Review

Orbis Investment Management (US) increased its Bristol-Myers Squibb (BMY) stake by 77% in Q4 2018, buying an estimated $2.1M and bringing the position to 89,763 shares worth $4.67M. The position accounts for 4.68% of the portfolio, ranked #10.

Orbis Investment Management (US) first reported a position in BMY in Q3 2017 and has held it in 5 quarters since. The position peaked at $7.51M in Q3 2017. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • Orbis Investment Management (US) held 89,763 shares of Bristol-Myers Squibb worth $4.67M as of Q4 2018.
  • Orbis Investment Management (US) bought 39,011 Bristol-Myers Squibb shares in Q4 2018, an estimated $2.1M.
  • Bristol-Myers Squibb made up 4.68% of Orbis Investment Management (US)'s portfolio in Q4 2018, its #10 holding.
  • Orbis Investment Management (US) first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 5 quarters since.
  • Orbis Investment Management (US)'s Bristol-Myers Squibb position peaked at $7.51M in Q3 2017.
  • 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Orbis Investment Management (US)'s 13F filing for Q4 2018, filed 14 Feb 2019.